Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 355

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 355
---
2023 (the “First Extension Meeting”).

On December 21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December 22, 2023 to March 22, 2024. In connection with the extension, 140,663 shares of the Company’s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock remaining outstanding after the Redemption are shares issued in connection with our initial public offering. In January 2024,
$1,565,078 was paid from the Trust Account to redeeming stockholders in connection with the extension.

On January 2, 2024, the
Company and Continental Stock Transfer & Trust Company (“CST”) entered into Amendment No. 1 to Investment Management
Trust Agreement, dated December 20, 2021, by and between the Company and CST, to allow CST, upon written instruction of the Company,
to (i) hold the funds in the Company’s trust account uninvested or (ii) hold the funds in an interest-bearing bank demand
deposit account.

On January 10, 2024,
the Company’s Board of Directors approved, and the Company amended, its Convertible Working Capital Promissory Note (the “Note”)
with the sponsor to increase the principal amount of the Note that could be drawn on to $1.5 million. The amended and restated Note
also allows for the conversion of the outstanding principal balance of the Note to be repaid in shares of Company common stock at a price
of $2.22 per share at the election of the sponsor. On May 31, 2024, the Company’s Board of Directors approved and the Company entered
into a second amendment of its Convertible Working Capital Promissory Note with the sponsor to increase the principal amount of the Note
that could be drawn on to $2.5 million. The second amended and restated Note also allows for the conversion of the outstanding principal
balance of the Note to be repaid in shares of Company common stock at a price of $2.22 per share at the election of the sponsor.

<div align='center'>F-60

NORTHVIEW ACQUISITION CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

Note 1 — Description of Organization and Business Operations